These results suggest acute Nav1.8 antagonism is effective at normalizing abnormal synchronous activity in the PTHS mouse model and provides further support that Nav1.8 may have utility for treating symptoms in PTHS. The gene discussed is SCN10A; the disease is Pitt-Hopkins syndrome.